Bell Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Bell Asset Management's ABBV Position: Q3 2026 in Review
Bell Asset Management reduced its AbbVie (ABBV) stake by 48% in Q3 2026, selling an estimated $2.58M and leaving 10,833 shares worth $2.83M. The position accounts for 1.02% of the portfolio, ranked #24.
Bell Asset Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.26M in Q2 2026. 2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Bell Asset Management held 10,833 shares of AbbVie worth $2.83M as of Q3 2026.
- Bell Asset Management sold 10,062 AbbVie shares in Q3 2026, an estimated $2.58M.
- AbbVie made up 1.02% of Bell Asset Management's portfolio in Q3 2026, its #24 holding.
- Bell Asset Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- Bell Asset Management's AbbVie position peaked at $5.26M in Q2 2026.
- 2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Bell Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.